Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of multiple intravenous
doses of pegol-Sihematide in participants with chronic kidney disease (CKD) who are on
dialysis.